Leptin enhances social motivation and reverses chronic unpredictable stress-induced social anhedonia during adolescence
- Yun Lei(corresponding author),
- Dan Wang,
- Yu Bai,
- Jayvon Nougaisse,
- ,
- Ming Guo
- ,
- Binzhou Medical University,
- Augusta University,
Open access
Sustainable Development Goals
- SDG 3 Good Health and Well
Abstract
Social anhedonia, a loss of interest and pleasure in social interactions, is a common symptom of major depression as well as other psychiatric disorders. Depression can occur at any age, but typically emerges in adolescence or early adulthood, which represents a sensitive period for social interaction that is vulnerable to stress. In this study, we evaluated social interaction reward using a conditioned place preference (CPP) paradigm in adolescent male and female mice. Adolescent mice of both sexes exhibited a preference for the social interaction-associated context. Chronic unpredictable stress (CUS) impaired the development of CPP for social interaction, mimicking social anhedonia in depressed adolescents. Conversely, administration of leptin, an adipocyte-derived hormone, enhanced social interaction-induced CPP in non-stressed control mice and reversed social anhedonia in CUS mice. By dissecting the motivational processes of social CPP into social approach and isolation avoidance components, we demonstrated that leptin treatment increased isolation aversion without overt social reward effect. Further mechanistic exploration revealed that leptin stimulated oxytocin gene transcription in the paraventricular nucleus of the hypothalamus, while oxytocin receptor blockade abolished the leptin-induced enhancement of socially-induced CPP. These results establish that chronic unpredictable stress can be used to study social anhedonia in adolescent mice and provide evidence that leptin modulates social motivation possibly via increasing oxytocin synthesis and oxytocin receptor activation.
Publication Information
Output type
Original language
English (US)Pages from-to (Number of pages)
Pages 4948-4958 (11 pages)Journal (Volume, Issue Number)
Molecular Psychiatry (Volume 27, Issue 12)Publication milestones
- Accepted/In press - 2022
- Published - 12/2022
Publication status
ISSN
1359-4184Publication IDs
- Scopus: 85138505560
- PubMed: 36138127
